Panbela Therapeutics Inc (OTCPK:PBLA)
$ 0.38 -0.025 (-6.17%) Market Cap: 1.84 Mil Enterprise Value: 5.90 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

Q2 2021 Panbela Therapeutics Inc Earnings Call Transcript

Aug 11, 2021 / 08:30PM GMT
Release Date Price: $57599.95 (-2.04%)
Operator

Greetings, and welcome to Panbela Therapeutics' Second Quarter 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, James Carbonara with Investor Relations. Thank you. You may begin.

James Carbonara
Hayden IR, LLC - Partner of IR Strategy & Operations

Thank you. And once again, welcome to Panbela's Second Quarter 2021 Earnings Call. With me on the call are Jennifer Simpson, Chief Executive Officer; and Sue Horvath, Chief Financial Officer.

Before I turn the call over to Dr. Simpson, please note that statements made on this call that are not historical facts may be forward-looking statements. Significant risks and uncertainties that could cause actual results to differ from those expressed or implied in the forward-looking statements are detailed in the company's annual report on Form 10-K and supplemented by subsequently filed reports on Form 10-Q as well as in other reports that the company has filed with the SEC. Any forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot